Calciphylaxis in end-stage renal disease patients

Author： Verdalles Ursula   García de Vinuesa Soledad   Luño José  

Publisher： Oxford University Press

ISSN： 1460-2385

Source： Nephrology Dialysis Transplantation, Vol.27, Iss.9, 2012-09, pp. : 3663-3663

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improved survival rate in patients with diabetes and end-stage renal disease in Denmark

By Sørensen V.   Mathiesen E.   Heaf J.   Feldt-Rasmussen B.  

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 922-929

Springer Publishing Company

Access to resources Recommend Favorite

The metabolic effects of troglitazone in patients with diabetes and end-stage renal disease

By Mohideen Pharis   Bornemann Michael   Sugihara Jared   Genadio Viola   Sugihara Valerie   Arakaki Richard  

Endocrine Journal, Vol. 28, Iss. 2, 2005-11 ,pp. : 181-186

Humana Press, Inc

Access to resources Recommend Favorite

Periprocedural Risk of Stroke Is Elevated in Patients with End-Stage Renal Disease on Hemodialysis

By  

Cerebrovascular Diseases Extra, Vol. 5, Iss. 3, 2015-0 ,pp. : 91-94

Karger

Access to resources Recommend Favorite

Bone Mineral Density in Kuwaiti Patients with End-Stage Renal Disease

By  

Medical Principles and Practice, Vol. 20, Iss. 2, 2011-01 ,pp. : 156-158

Karger

Access to resources Recommend Favorite

Anti-Carbonic Anhydrase II Antibodies in End-Stage Renal Disease Patients

By  

Medical Principles and Practice, Vol. 23, Iss. 4, 2014-06 ,pp. : 331-335

Karger

Access to resources Recommend Favorite